A rapid in vivo screen for pancreatic ductal adenocarcinoma therapeutics

Pancreatic ductal adenocarcinoma (PDA) is the fourth leading cause of cancer-related deaths in the United States, and is projected to be second by 2025. It has the worst survival rate among all major cancers. Two pressing needs for extending life expectancy of affected individuals are the developmen...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Dis Model Mech
Main Authors: Ocal, Ozhan, Pashkov, Victor, Kollipara, Rahul K., Zolghadri, Yalda, Cruz, Victoria H., Hale, Michael A., Heath, Blake R., Artyukhin, Alex B., Christie, Alana L., Tsoulfas, Pantelis, Lorens, James B., Swift, Galvin H., Brekken, Rolf A., Wilkie, Thomas M.
Formato: Artigo
Idioma:Inglês
Publicado em: The Company of Biologists 2015
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4610235/
https://ncbi.nlm.nih.gov/pubmed/26438693
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1242/dmm.020933
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados